Adult Growth Hormone Deficiency Market Size, Epidemiology, Pipeline, Therapies, Companies and Competitive Analysis by DelveInsight

Adult Growth Hormone Deficiency (AGHD) is a medical condition that occurs when the pituitary gland in brain does not produce enough growth hormone. Most cases of Adult Growth Hormone Deficiency (AGHD) result from damage to the pituitary gland caused by a pituitary tumor or by treatment for this using surgery and/or radiotherapy. Adult Growth Hormone Deficiency (AGHD) is treated with growth hormone replacement therapy. The growth hormone that is used is an artificial preparation that individuals can administer themselves.

DelveInsight’s “Adult Growth Hormone Deficiency Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Adult Growth Hormone Deficiency, historical and forecasted epidemiology as well as the Adult Growth Hormone Deficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some facts of Adult Growth Hormone Deficiency Market are:

• According to D B Allen et al., about 15%-20% of the cases represent the transition of childhood GH deficiency into adulthood.
• As per Jana Bujanova et al., estimates prevalence of AGHD in the UK is approximately 1 in 10 000 (a total of approximately 6380 patients). If Childhood-onset GH deficiency is added to this number then prevalence is 1 in 10 000 to 1 in 3500.
• In a study, the author found that a greater proportion of Japanese adults had AO GHD than CO GHD, a finding similar to those of previous studies in Caucasian adults. In contrast, in a previous study of Japanese adults with GHD, only 45% of participants were reported to have AO GHD. That study, however, included a smaller number of participants than were included in the study and was conducted at a single institution. [Akira Shimatsu et al.,2011]
• Adult Growth Hormone Deficiency is more common among males than females.

Scope of the Adult Growth Hormone Deficiency MarketReport

• The report covers the descriptive overview of Adult Growth Hormone Deficiency, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies.
• Comprehensive insight has been provided into the Adult Growth Hormone Deficiency epidemiology and treatment in the 7MM.
• Additionally, an all-inclusive account of both the current and emerging therapies for Adult Growth Hormone Deficiency is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape.
• A detailed review of the Adult Growth Hormone Deficiency market; historical and forecasted is included in the report, covering drug outreach in the 7MM.
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Adult Growth Hormone Deficiency market.

Some of Adult Growth Hormone Deficiency Companies are:

• Novo Nordisk
• Ascendis Pharma
• And Many Others

Some of Adult Growth Hormone Deficiency Therapies are:

• Sogroya (somapacitan-beco)
• TransCon hGH
• And Many Others

Table of Contents:

1. Key Insights

2. Executive Summary of Adult Growth Hormone Deficiency

3. Competitive Intelligence Analysis for Adult Growth Hormone Deficiency

4. Adult Growth Hormone Deficiency: Market Overview at a Glance

5. Adult Growth Hormone Deficiency: Disease Background and Overview

5.1. Introduction

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Adult Growth Hormone Deficiency Treatment

11. Marketed Products

List to be continued in report

12. Emerging Therapies

List to be continued in report

13. Adult Growth Hormone Deficiency: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Adult Growth Hormone Deficiency

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

Request for Detailed TOC: https://www.delveinsight.com/sample-request/acanthamoeba-keratitis-market

Some of Newly Launched Report: 

• NCFB Market
• Metastatic Bone Pain Market
• Ventricular Hypertrophy Market
• Diagnostic Imaging Equipment Market
• Invasive Candidiasis Market
• Upper Limb Hypertonia Market
• Sialidosis Market
• Filgrastim Biosimilar Insight
• 3D Cardiac Mapping System Market
• Acanthamoeba Keratitis Market
• Adult Growth Hormone Deficiency Market
• Advanced Cancer Pain Management Market
• Apheresis Market
• Arteriovenous fistula Market
• Automated external defibrillators (AEDs) Market
• Balloon Catheters Market
• Calciphylaxis Market
• Cerebral Aneurysm Market
• Chronic Idiopathic Urticaria Market

Related Blogs:

• Most Promising Applications of Artificial Intelligence (AI) in Healthcare Segment
• Mapping the Biggest Pharmaceutical Companies by Continents
• Widespread Usage of HPV Vaccine Reduces Cervical Cancers and Precancers
• Major Drugs Decisions for Cardiovascular Diseases to Watch Through 2022
• Assessment of Key Products that Got FDA Approval in Second Half (H2) of 2021
• Evaluation of Rapidly Evolving Parkinson’s Disease Therapeutic Market
• Cybersecurity in Healthcare: Major Threats and Challenges
• Top Drugs To Watch in HIV (2025)

About Delveinsight: 

DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.

Media Contact

 Company Name: DelveInsight Business Research LLP

 Contact Person: Ankit Nigam

 Email: info@delveinsight.com

 Phone: +19193216187

 City: Albany

 State: New York

 Country: United States

 Website: https://www.delveinsight.com